Hua Medicine (Shanghai) Ltd. - Laporan Laba Rugi (TTM)

Hua Medicine (Shanghai) Ltd.
HK ˙ SEHK ˙ KYG4644K1022
HK$ 4.49 ↓ -0.10 (-2.18%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Hua Medicine (Shanghai) Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 16 9 9 9 4 -0 -0 9 18 53 88 82 77 93 109 182 256 313 371
Change (%) -44.47 0.89 0.88 -50.00 -105.45 100.00 -1,879.42 105.62 199.82 66.65 -6.44 -6.88 21.10 17.42 67.44 40.28 22.43 18.32
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5 10 23 36 38 39 54 68 100 131 154 176
Change (%) 100.00 132.61 57.01 4.20 4.03 36.47 26.72 46.66 31.81 17.04 14.56
% of Revenue 57.89 56.31 43.69 41.16 45.84 51.22 57.71 62.28 54.55 51.26 49.01 47.45
Gross Operating Profit 16 9 9 9 4 -0 -0 4 8 30 52 45 37 39 41 83 125 160 195
Change (%) -44.47 0.89 0.88 -50.00 -105.45 100.00 -849.27 113.35 286.43 74.12 -13.88 -16.12 4.97 4.73 101.77 50.44 28.08 21.93
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 42.11 43.69 56.31 58.84 54.16 48.78 42.29 37.72 45.45 48.74 50.99 52.55
SG&A 138 140 140 139 137 137 140 143 145 164 184 194 204 212 219 245 270 267 265
Change (%) 1.26 -0.26 -0.26 -1.62 0.18 1.83 1.94 1.90 13.22 11.67 5.50 5.22 3.75 3.61 11.58 10.38 -0.92 -0.92
% of Revenue 886.61 1,616.85 1,598.43 1,580.34 3,109.42 -57,107.69 -29,075.47 1,665.69 825.50 311.72 208.89 235.56 266.16 228.01 201.19 134.07 105.49 85.38 71.49
R&D 244 221 214 207 197 174 161 145 130 129 128 150 172 196 220 218 215 188 161
Change (%) -9.56 -3.23 -3.34 -4.80 -11.58 -7.38 -9.81 -10.88 -0.50 -0.50 16.88 14.44 14.22 12.45 -1.19 -1.20 -12.54 -14.34
% of Revenue 1,565.78 2,550.35 2,446.25 2,343.97 4,462.76 -72,343.87 -33,500.83 1,698.02 736.00 244.26 145.84 182.19 223.91 211.18 202.23 119.34 84.06 60.05 43.47
OpEx 383 361 354 346 334 311 301 293 285 316 348 381 415 461 507 562 616 609 602
Change (%) -5.64 -2.08 -2.12 -3.52 -6.75 -3.32 -2.70 -2.78 11.13 10.02 9.56 8.73 11.17 10.05 10.73 9.69 -1.15 -1.16
% of Revenue 2,452.38 4,167.20 4,044.68 3,924.30 7,572.18 -129,451.56 -62,576.30 3,421.60 1,617.80 599.68 395.90 463.59 541.28 496.91 465.71 307.96 240.80 194.43 162.42
Operating Income -367 -352 -345 -337 -329 -312 -301 -284 -267 -264 -260 -299 -338 -368 -398 -379 -360 -296 -231
Change (%) -3.99 -2.15 -2.20 -2.31 -5.43 -3.24 -5.70 -6.04 -1.30 -1.31 14.97 13.02 8.92 8.19 -4.78 -5.02 -17.90 -21.80
% of Revenue -2,352.38 -4,067.20 -3,944.68 -3,824.30 -7,472.18 129,551.56 62,676.30 -3,321.60 -1,517.80 -499.68 -295.90 -363.59 -441.28 -396.91 -365.71 -207.96 -140.80 -94.43 -62.42
Interest Expense -4 -4 -4 -4 -4 -4 -4 -4 -4 -5 -5 -7 -8 -8 -8 -8 -9 -9 -9
Change (%) 18.47 -2.82 -2.90 -2.39 -4.84 -2.52 -1.18 -1.20 23.51 19.03 23.34 18.92 2.22 2.17 2.13 2.08 0.51 0.51
% of Revenue -23.78 -50.74 -48.87 -47.04 -91.83 1,602.08 780.87 -43.36 -20.84 -8.58 -6.13 -8.08 -10.32 -8.71 -7.58 -4.62 -3.36 -2.76 -2.35
Net Income -378 -393 -389 -385 -355 -295 -265 -234 -204 -196 -189 -200 -211 -237 -263 -257 -250 413 1,076
Change (%) 3.95 -1.04 -1.05 -7.69 -16.87 -10.27 -11.61 -13.14 -3.57 -3.70 5.89 5.56 12.34 10.99 -2.51 -2.58 -265.08 160.57
% of Revenue -2,423.76 -4,537.56 -4,450.89 -4,365.74 -8,059.71 122,826.40 55,106.24 -2,737.28 -1,156.36 -371.93 -214.93 -243.23 -275.73 -255.78 -241.76 -140.76 -97.75 131.82 290.30

Source: Capital IQ

Other Listings
US:HUMDF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista